| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
1993-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d9fcf4ce3c1b0baf569dc846c4486a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3c0319b90260f1bbb919d8fa722c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feae499433b1097200af8b0c3d1e8a52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b069e9e8e64752866e9835f5e1ca4400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67fb2f5da667a32487c3f925ab4975b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7f309e46f1dd9fe6033fc7eb6f5675 |
| publicationDate |
2002-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-290612-B6 |
| titleOfInvention |
Contraceptive and contraceptive compounds |
| abstract |
The use of a competitive progesterone antagonist for the manufacture of a pharmaceutical for contraception in females in a dosage amount that is less than the ovulation-inhibiting dose and less than the abortion-inducing dose effective to inhibit endometrial gland formation and epithelial growth and / or glandular function inhibition it is essential for successful implantation, for administration during the follicular phase of the female's menstrual cycle and possibly also in the luteal phase. |
| priorityDate |
1992-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |